The Food and Drug Administration has issued an interim final rule, with a comment period, that makes changes to how pharmaceutical firms report drug shortages.

Under current law, companies that are the sole manufacturer of certain drug products must notify the FDA at least six months before discontinuing the manufacturing of a product. These include FDA-approved products that are life supporting, life sustaining or used to prevent debilitating diseases or conditions, and are not originally derived from human issue and replaced by a recombinant product.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access